Get the Stockscreener App
635.54
0.18%
-1.16
After Hours:
635.54
Idexx Laboratories Inc stock is traded at $635.54, with a volume of 501.48K.
It is down -0.18% in the last 24 hours and up +0.47% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
See More
Previous Close:
$636.70
Open:
$627.91
24h Volume:
501.48K
Relative Volume:
0.99
Market Cap:
$50.60B
Revenue:
$4.30B
Net Income/Loss:
$1.06B
P/E Ratio:
48.59
EPS:
13.0798
Net Cash Flow:
$1.04B
1W Performance:
-2.11%
1M Performance:
+0.47%
6M Performance:
+0.25%
1Y Performance:
+45.38%
1-Day Range:
$624.95
$644.20
1-Week Range:
$624.95
$666.14
52-Week Range:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
635.54 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
TMO
Thermo Fisher Scientific Inc
|
508.10 | 191.08B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.01 | 145.67B | 24.57B | 3.60B | 5.26B | 5.051 |
|
A
Agilent Technologies Inc
|
119.04 | 33.42B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
312.14 | 30.14B | 3.17B | 642.63M | 516.49M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
IDEXX Laboratories (NASDAQ:IDXX) CEO Sells $15,338,011.30 in Stock - MarketBeat
IDEXX Laboratories CEO Jonathan Jay Mazelsky Sells Over 23,000 Shares - TradingView
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch
IDEXX Laboratories, Inc. (IDXX) - DirectorsTalk Interviews
IDEXX Labs at Raymond James Conference: Innovation and Growth Strategy - Investing.com
Transcript : IDEXX Laboratories, Inc. Presents at 47th Annual Raymond James Institutional Investor Conference, Mar-02-2026 09 - marketscreener.com
IDEXX Laboratories, Inc. $IDXX Shares Sold by Davis R M Inc. - MarketBeat
Aster Capital Management DIFC Ltd Sells 3,735 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Analysis Recap: Can IDEXX Laboratories Inc keep up with sector leaders2025 Key Lessons & Proven Capital Preservation Tips - baoquankhu1.vn
William Blair Investment Management LLC Trims Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Rafferty Asset Management LLC Sells 3,443 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Erste Asset Management GmbH Sells 4,665 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Andra AP fonden Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
American Century Companies Inc. Has $450.52 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Wall Street Zen Downgrades IDEXX Laboratories (NASDAQ:IDXX) to Buy - MarketBeat
IDEXX Laboratories Touts “Exceptional” Q4, Targets 8%-10% 2026 Growth at BofA Summit - Yahoo Finance
Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) EVP Sells 2,693 Shares of Stock - MarketBeat
IDEXX Laboratories Executive Sells Shares - TradingView
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775 - 富途牛牛
94,129 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Westfield Capital Management Co. LP - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stake Raised by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
IDEXX Labs at BofA Summit: Strong Growth Amid Challenges - Investing.com Nigeria
Montrusco Bolton Investments Inc. Cuts Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
TD Asset Management Inc Sells 25,321 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
[144] IDEXX LABORATORIES INC /DE SEC Filing - Stock Titan
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $790 - 富途牛牛
Investment Review: Can IDEXX Laboratories Inc sustain earnings growthQuarterly Portfolio Report & Weekly Breakout Watchlists - baoquankhu1.vn
Waratah Capital Advisors Ltd. Cuts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Weitz Investment Management Inc. Lowers Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Jacobson & Schmitt Advisors LLC Sells 6,794 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Dakota Wealth Management Raises Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc (IDXX) Shares Up 3.23% on Feb 24 - GuruFocus
IDEXX Laboratories (IDXX) Rallied in Q2. Here’s Why - MSN
Breakouts Watch: Is IDEXX Laboratories Inc attractive for institutional investorsWeekly Investment Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
LGT Capital Partners LTD. Reduces Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Generation Investment Management LLP Has $166.36 Million Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX) - Finviz
Here's What Analysts Are Saying About IDEXX Laboratories (IDXX) - Bitget
Here’s What Analysts Are Saying About IDEXX Laboratories (IDXX) - Insider Monkey
Marks Group Wealth Management Inc Sells 1,839 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Citigroup Inc. Buys 7,670 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stock Holdings Lowered by Premier Fund Managers Ltd - MarketBeat
Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) Director Sells $920,299.68 in Stock - Defense World
Axxcess Wealth Management LLC Decreases Position in IDEXX Laboratories, Inc. $IDXX - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Raiffeisen Bank International AG Has $35.07 Million Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Michael Erickson Sells 5,371 Shares of IDEXX Laboratories (NASDAQ:IDXX) Stock - Defense World
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
What is the Moat Score of IDEXX Laboratories Inc.July 2025 Breakouts & Verified Momentum Watchlists - mfd.ru
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.74%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):